Georgetown University
- Country
- ๐ฌ๐นGuatemala
- Ownership
- Private
- Established
- 1789-01-23
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.georgetown.edu
Phase I Study of CS-7017 and Bexarotene
- Conditions
- Interventions
- First Posted Date
- 2012-01-05
- Last Posted Date
- 2017-02-14
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 9
- Registration Number
- NCT01504490
- Locations
- ๐บ๐ธ
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer
- First Posted Date
- 2012-01-05
- Last Posted Date
- 2020-03-16
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 6
- Registration Number
- NCT01504477
- Locations
- ๐บ๐ธ
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
- First Posted Date
- 2011-12-22
- Last Posted Date
- 2015-12-16
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 34
- Registration Number
- NCT01497652
- Locations
- ๐บ๐ธ
Georgetown University Hospital, Washington, District of Columbia, United States
Lapatinib and Bortezomib in Patients With Advanced Malignancies
- First Posted Date
- 2011-12-22
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 15
- Registration Number
- NCT01497626
- Locations
- ๐บ๐ธ
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer
- First Posted Date
- 2011-12-12
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 64
- Registration Number
- NCT01489865
- Locations
- ๐บ๐ธ
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer
- First Posted Date
- 2011-12-02
- Last Posted Date
- 2018-02-09
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 12
- Registration Number
- NCT01484041
- Locations
- ๐บ๐ธ
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
Determination of the Pathophysicologic Collagen Changes in the Diabetic Achilles Tendon
- Conditions
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 10
- Registration Number
- NCT01382628
- Locations
- ๐บ๐ธ
Georgetown University Hospital Center for Wound Healing, Washington, District of Columbia, United States
VAC NPWT KCI Dressing Study
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- Georgetown University
- Registration Number
- NCT01366105
- Locations
- ๐บ๐ธ
Georgetown University Hospital, Washington, District of Columbia, United States
Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU)
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 11
- Registration Number
- NCT01356147
- Locations
- ๐บ๐ธ
Georgetown University Hospital, Washington, District of Columbia, United States
๐บ๐ธGeorgetown University Hospital NICU, Washington, District of Columbia, United States
Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet
- First Posted Date
- 2011-03-28
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 45
- Registration Number
- NCT01324245
- Locations
- ๐บ๐ธ
Georgetown University Medical Center, Washington, District of Columbia, United States